These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 20420434)

  • 1. Comparison of three preprocessing filters efficiency in virtual screening: identification of new putative LXRbeta regulators as a test case.
    Ghemtio L; Devignes MD; Smaïl-Tabbone M; Souchet M; Leroux V; Maigret B
    J Chem Inf Model; 2010 May; 50(5):701-15. PubMed ID: 20420434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-dimensional pharmacophore modeling of liver-X receptor agonists.
    Zhao W; Gu Q; Wang L; Ge H; Li J; Xu J
    J Chem Inf Model; 2011 Sep; 51(9):2147-55. PubMed ID: 21434646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of new liver X receptor agonists by pharmacophore modeling and shape-based virtual screening.
    Temml V; Voss CV; Dirsch VM; Schuster D
    J Chem Inf Model; 2014 Feb; 54(2):367-71. PubMed ID: 24502802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting selective liver X receptor β agonists using multiple machine learning methods.
    Li Y; Wang L; Liu Z; Li C; Xu J; Gu Q; Xu J
    Mol Biosyst; 2015 May; 11(5):1241-50. PubMed ID: 25734698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of novel liver X receptor activators by structure-based modeling.
    von Grafenstein S; Mihaly-Bison J; Wolber G; Bochkov VN; Liedl KR; Schuster D
    J Chem Inf Model; 2012 May; 52(5):1391-400. PubMed ID: 22489742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel formulation of veggies with potent liver detoxifying activity.
    Jain MM; Kumari N; Rai G
    Int J Comput Biol Drug Des; 2015; 8(1):75-86. PubMed ID: 25869321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A fragment-based approach for ligand binding affinity and selectivity for the liver X receptor beta.
    Salum LB; Andricopulo AD; Honório KM
    J Mol Graph Model; 2012 Feb; 32():19-31. PubMed ID: 22030023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. X-ray structures of the LXRalpha LBD in its homodimeric form and implications for heterodimer signaling.
    Fradera X; Vu D; Nimz O; Skene R; Hosfield D; Wynands R; Cooke AJ; Haunsø A; King A; Bennett DJ; McGuire R; Uitdehaag JC
    J Mol Biol; 2010 May; 399(1):120-32. PubMed ID: 20382159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A steered molecular dynamics mediated hit discovery for histone deacetylases.
    Kalyaanamoorthy S; Chen YP
    Phys Chem Chem Phys; 2014 Feb; 16(8):3777-91. PubMed ID: 24429775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery and Synthesis of a Novel Series of Liver X Receptor Antagonists.
    Nian S; Gan X; Tan X; Yu Z; Wang P; Chen X; Wang G
    Chem Pharm Bull (Tokyo); 2015; 63(8):628-35. PubMed ID: 26062802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of novel serotonin 2C receptor ligands by sequential virtual screening.
    Ahmed A; Choo H; Cho YS; Park WK; Pae AN
    Bioorg Med Chem; 2009 Jul; 17(13):4559-68. PubMed ID: 19464901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virtual high throughput screening in new lead identification.
    Badrinarayan P; Sastry GN
    Comb Chem High Throughput Screen; 2011 Dec; 14(10):840-60. PubMed ID: 21843146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent trends and applications in 3D virtual screening.
    Ghemtio L; Perez-Nueno VI; Leroux V; Asses Y; Souchet M; Mavridis L; Maigret B; Ritchie DW
    Comb Chem High Throughput Screen; 2012 Nov; 15(9):749-69. PubMed ID: 22934947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple pharmacophore models combined with molecular docking: a reliable way for efficiently identifying novel PDE4 inhibitors with high structural diversity.
    Chen Z; Tian G; Wang Z; Jiang H; Shen J; Zhu W
    J Chem Inf Model; 2010 Apr; 50(4):615-25. PubMed ID: 20353193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Machine learning in computational docking.
    Khamis MA; Gomaa W; Ahmed WF
    Artif Intell Med; 2015 Mar; 63(3):135-52. PubMed ID: 25724101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploration of the structural requirements of HIV-protease inhibitors using pharmacophore, virtual screening and molecular docking approaches for lead identification.
    Islam MA; Pillay TS
    J Mol Graph Model; 2015 Mar; 56():20-30. PubMed ID: 25541527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virtual high throughput screening (vHTS)--a perspective.
    Subramaniam S; Mehrotra M; Gupta D
    Bioinformation; 2008; 3(1):14-7. PubMed ID: 19052660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virtual screening of biogenic amine-binding G-protein coupled receptors: comparative evaluation of protein- and ligand-based virtual screening protocols.
    Evers A; Hessler G; Matter H; Klabunde T
    J Med Chem; 2005 Aug; 48(17):5448-65. PubMed ID: 16107144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LXR{beta} is the dominant LXR subtype in skeletal muscle regulating lipogenesis and cholesterol efflux.
    Hessvik NP; Boekschoten MV; Baltzersen MA; Kersten S; Xu X; Andersén H; Rustan AC; Thoresen GH
    Am J Physiol Endocrinol Metab; 2010 Mar; 298(3):E602-13. PubMed ID: 19996385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient method for high-throughput virtual screening based on flexible docking: discovery of novel acetylcholinesterase inhibitors.
    Mizutani MY; Itai A
    J Med Chem; 2004 Sep; 47(20):4818-28. PubMed ID: 15369385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.